Meridian Clinical Laboratory Corp is categorized under Medical Labs in Miami, FL and active since 2012.
Meridian Clinical Laboratory Corp was established in 2012, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Medical Labs business, which does work in the B2C market, and is classified as a Medical Labs, under code number 621511 by the NAICS.
If you are seeking more information, feel free to contact Carlos Acosta at the company’s single location by writing to 300 Sw 107th Avenue # 209, Miami, Florida FL 33174 or by phoning (305) 554-9790. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Meridian Clinical Laboratory Corp |
| Contact Person: | Carlos Acosta |
| Address: | 300 Sw 107th Avenue # 209, Miami, Florida 33174 |
| Phone Number: | (305) 554-9790 |
| Website Address: | bioreference.com |
| Annual Revenue (USD): | $100.000 to $499.999 |
| Founded: | 2012 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Medical Labs |
| SIC Code: | 8071 |
| NAICS Code: | 621511 |
| Share This Business: |
Meridian Clinical Laboratory Corp was started in 2012 to provide professional Medical Labs under the SIC code 8071 and NAICS code 621511. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.
Feel free to contact Carlos Acosta for inquiries that concern Meridian Clinical Laboratory Corp by calling the company number (305) 554-9790, as your correspondence is most welcome. Additionally, the physical location of the single location of Meridian Clinical Laboratory Corp can be found at the coordinates 25.765306,-80.368947 as well as the street address 300 Sw 107th Avenue # 209 in Miami, Florida 33174.
For its online presence, you may visit Meridian Clinical Laboratory Corp’s website at bioreference.com and engage with its social media outlets through on Twitter and on Facebook.